查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552874

植入式給藥裝置市場規模、佔有率和趨勢分析報告：2024-2030 年按產品、類型、技術、應用、地區和細分市場進行的預測

Implantable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Type (Biodegradable, Nonbiodegradable), By Technology, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

植入式給藥裝置市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，到2030年，全球植入式給藥裝置市場規模預計將達到470.1億美元，2024年至2030年複合年成長率為8.2%。

慢性病盛行率的增加和對微創治療方案的需求不斷成長正在推動植入式藥物傳輸設備市場的發展。

藥物傳輸技術的最新進展預計將在預測期內推動市場成長。微型植入設備的日益普及也是推動成長的關鍵因素之一。這些產品可用於改善身體功能、影像和監測藥物管理。受控藥物輸送有利於局部治療並使治療劑有針對性地輸送到組織。

這些設備有助於克服靜脈、口服和局部給藥途徑的局限性，並拓寬市場的成長前景。此外，生物分解性植入的出現使得將化療標靶遞送至癌細胞而不損害正常細胞成為可能。藥物釋放植入還可以幫助治療無法手術的腫瘤，例如肝臟、大腦和肺部的腫瘤。這些設備有助於縮小腫瘤，從而可以透過手術切除腫瘤。這些設備的上述優點預計將在預測期內推動其採用。

新興市場正致力於開發新型藥物輸送裝置，以佔領最大的市場佔有率，從而在市場上推出各種技術先進的產品。例如，2017年2月，美國生技公司Delpor, Inc.宣布推出用於長期輸送治療劑的植入式裝置。

植入式給藥裝置市場報告亮點

  • 從產品來看，藥物釋放型支架將在 2023 年佔據市場主導地位，因為它們在荷爾蒙調節、避孕、疼痛管理和癌症治療中的應用越來越廣泛。另一方面，由於周邊動脈疾病和冠狀動脈疾病的盛行率不斷增加，預計生物可吸收支架將出現良好的成長。
  • 按產品類型分類，非生物分解部分在 2023 年佔據最大佔有率。
  • 從技術角度來看，擴散型佔據了市場的主導佔有率，由於患者預後和可接受性的改善，採用率顯著增加。
  • 同時，由於多發性硬化症和類風濕性關節炎的盛行率不斷上升，預計自體免疫疾病將呈現最快的複合年成長率。
  • 由於慢性病患病率上升、不健康的生活方式和高壓力水平，北美在 2023 年佔據了相當大的佔有率，而亞太地區預計到 2025 年將實現較大的複合年成長率。這是由於醫療保健系統的改善、醫療成本的增加和意識的提高。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 植入式給藥裝置市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 植入式給藥裝置市場分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 植入式給藥裝置市場：依產品估計與趨勢分析

  • 細分儀表板
  • 植入式給藥裝置市場：2023 年及 2030 年產品變化分析
  • 避孕植入
  • 脊椎移植
  • 近距離放射治療種子線
  • 藥物釋放型支架
  • 生物可吸收支架
  • 眼內植入
  • 點滴幫浦
  • 其他

第5章 植入式給藥裝置市場：按類型估計和趨勢分析

  • 細分儀表板
  • 植入式給藥裝置市場：類型變化分析，2023 年和 2030 年
  • 生物分解性
  • 不可生物分解性

第6章 植入式給藥裝置市場：依技術估算與趨勢分析

  • 細分儀表板
  • 植入式給藥裝置市場：2023 年及 2030 年技術變遷分析
  • 擴散
  • 滲透壓
  • 磁的
  • 其他

第7章 植入式給藥裝置市場：依應用估計與趨勢分析

  • 細分儀表板
  • 植入式給藥裝置市場：2023 年和 2030 年按應用分類的變化分析
  • 避孕
  • 眼科
  • 心血管
  • 糖尿病
  • 腫瘤學
  • 自體免疫疾病
  • 其他

第8章植入式給藥裝置市場：區域估計與趨勢分析

  • 2023年及2030年植入式給藥裝置按地區市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Medtronic
    • Boston Scientific Corporation
    • Allergan
    • Merck &Co., Inc.
    • Bausch and Lomb Incorporated
    • Bayer AG
    • Abbott
    • Teleflex Incorporated
    • Varian Medical Systems, Inc.
簡介目錄
Product Code: GVR-2-68038-497-0

Implantable Drug Delivery Devices Market Growth & Trends:

The global implantable drug delivery devices market size is expected to reach USD 47.01 billion by 2030, registering to grow at a CAGR of 8.2% from 2024 to 2030 according to a new report by Grand View Research, Inc. The growing incidence of chronic diseases, coupled with rising demand for minimally invasive treatment options, is driving the market for implantable drug delivery devices.

Recent advancements in medication administration technologies are expected to fuel market growth over the forecast period. An increase in the adoption of micro-scale implantable devices is one of the key factors fueling growth. These products find application in monitoring improvement in body functions, imaging, and medication administration. They facilitate localized treatment with controlled drug administration and enable targeted delivery of therapeutics to tissues.

These devices help overcome limitations of intravenous, oral, and topical administration routes, thus broadening the growth prospects of the market. In addition, the advent of biodegradable implants enables the targeted delivery of chemotherapeutics to tumor cells without damaging normal cells. Drug releasing implants are also helpful in the treatment of inoperable tumors such as that of the liver, brain, and lungs, due to their location and size. These devices help in reducing tumor size, which enables the surgical removal of tumors. The aforementioned benefits of these devices are expected to impel their adoption over the forecast period.

Manufacturers are focused on developing novel drug delivery devices to gain maximum market share, which has resulted in the launch of various technologically advanced products in the market. For instance, in February 2017, Delpor, Inc., a biotechnology company in U.S., announced the launch of an implantable device for the long-term delivery of therapeutics.

Implantable Drug Delivery Devices Market Report Highlights:

  • By product, drug-eluting stents held a dominant share in the market in 2023, owing to their growing adoption in hormone regulation, contraception, pain management, and cancer therapy. Bio-absorbable stents, on the other hand, are anticipated to grow at a lucrative rate owing to the increase in incidence of peripheral and coronary artery diseases
  • On the basis of type, the non-biodegradable segment held the largest share in 2023, as a consequence of easy availability of these products and their established efficacy
  • Diffusion held a dominant share in the market on the basis of technology, owing to a significant increase in adoption as it offers better patient outcomes and acceptability
  • Autoimmune diseases, on the other hand, are expected to exhibit the fastest CAGR owing to rising prevalence of multiple sclerosis and rheumatoid arthritis
  • While North America held a substantial share in 2023 owing to the rising prevalence of chronic diseases, unhealthy lifestyles, and high-stress levels among the population, Asia Pacific is anticipated to achieve significant CAGR through 2025. This is owing to improving healthcare systems, rising healthcare expenditure, and growing awareness.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market
  • 1.2. Segmentation and Scope
  • 1.3. Market Definitions
  • 1.4. Research Methodology
    • 1.4.1. Information Procurement
    • 1.4.2. Information or Data Analysis
    • 1.4.3. Market Formulation & Data Visualization
    • 1.4.4. Data Validation & Publishing
  • 1.5. Research Scope and Assumptions
    • 1.5.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Implantable Drug Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Implantable Drug Delivery Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Implantable Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Implantable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Contraceptive Implants
    • 4.3.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Spinal Implants
    • 4.4.1. Spinal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Brachytherapy Seeds
    • 4.5.1. Brachytherapy Seeds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Drug Eluting Stents
    • 4.6.1. Drug Eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Bioabsorbable Stents
    • 4.7.1. Bioabsorbable Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Intraocular Implants
    • 4.8.1. Intraocular Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
  • 4.9. Infusion Pumps
    • 4.9.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 5. Implantable Drug Delivery Devices Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Implantable Drug Delivery Devices Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Biodegradable
    • 5.3.1. Biodegradable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Non-biodegradable
    • 5.4.1. Non-biodegradable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Implantable Drug Delivery Devices Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Implantable Drug Delivery Devices Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Diffusion
    • 6.3.1. Diffusion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Osmotic
    • 6.4.1. Osmotic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Magnetic
    • 6.5.1. Magnetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Implantable Drug Delivery Devices Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Implantable Drug Delivery Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Contraception
    • 7.3.1. Contraception Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Ophthalmology
    • 7.4.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Cardiovascular
    • 7.5.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Diabetes
    • 7.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Oncology
    • 7.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Autoimmune Diseases
    • 7.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Implantable Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 8.1. Implantable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.K.
      • 8.3.2.1. U.K. Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Medtronic
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Boston Scientific Corporation
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Allergan
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Merck & Co., Inc.
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Bausch and Lomb Incorporated
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Bayer AG
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Abbott
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Teleflex Incorporated
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Varian Medical Systems, Inc.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives